Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Need cash fast? Explore various ways to get instant cash from home and improve your financial situation today.
20,693 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
After-hours moves often reveal the next chapter for crypto firms. Gemini shares rise after hours as investors embrace...
When the market's fear gauge just spiked, investors wonder what comes next for AI stocks. This guide breaks down the ...
From a couch-bound gamer to a Big Ten Player of the Year, Yaxel Lendeborg is redefining more than basketball — he’s i...
A wave of new positions from hedge funds loading boeing points to a cautious but growing bet that Boeing can rebound ...
A 2025 performance-year pay surge pushed the average wall street bonus to around $210,000, about three times the typi...
NVIDIA’s shares hover near $198 as investors weigh whether the AI leader’s growth justifies a premium. The stock now ...
California luxury builder Thomas James Homes announces a new growth plan under CEO Steve Schlageter, centering on pre...
Investors are watching Eli Lilly as GLP-1 drugs like Mounjaro and Zepbound power growth. This article breaks down the...
Morgan Stanley’s bitcoin ETF attracted $194 million in its first month, with no net daily outflows, signaling growing...
The AI rally has expanded beyond the marquee leaders, lifting a wider group of software and cybersecurity names. Anal...
Two leading banks issued contrasting views on AMD in a single day, underscoring a broader divide in how investors pri...